Pharmaceutical sales rose by 12.6% in Bulgaria in 2002, compared with 2001, to reach $US293.1 million

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.413, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sales for Krka and Lek, the two largest pharmaceutical companies in Slovenia, rose by 10.2% and 51.9% in 2003 to reach Tol97 billion and Tol145 billion, respectively

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

National spending on health in constant prices rose by 3% in Israel in 2002, compared with a 4% rise in 2001

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 430, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pharmaceutical sales up by 11.6% in 2002 in Norway

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 411, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Global over-the-counter (OTC) drug sales for Novartis rose 5% in 2001

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 350, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Pharmaceutical Conferences: October 2001 - July 2002

Pharmaceutical Innovation, Vol. 10, Iss. 6, 2001-10 ,pp. : 54-54

Adis International

Access to resources Recommend Favorite